ATE503758T1 - Verfahren zur herstellung einer kristallinen pyrazoloä1,5-aüpyrimidinverbindung - Google Patents

Verfahren zur herstellung einer kristallinen pyrazoloä1,5-aüpyrimidinverbindung

Info

Publication number
ATE503758T1
ATE503758T1 AT07821163T AT07821163T ATE503758T1 AT E503758 T1 ATE503758 T1 AT E503758T1 AT 07821163 T AT07821163 T AT 07821163T AT 07821163 T AT07821163 T AT 07821163T AT E503758 T1 ATE503758 T1 AT E503758T1
Authority
AT
Austria
Prior art keywords
aüpyrimidine
crystalline
compound
producing
aüpyrimidine compound
Prior art date
Application number
AT07821163T
Other languages
English (en)
Inventor
Luis Anglada
Albert Palomer
Antonio Guglietta
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Application granted granted Critical
Publication of ATE503758T1 publication Critical patent/ATE503758T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT07821163T 2006-10-11 2007-10-10 Verfahren zur herstellung einer kristallinen pyrazoloä1,5-aüpyrimidinverbindung ATE503758T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85101106P 2006-10-11 2006-10-11
EP06122143A EP1956021A1 (de) 2006-10-11 2006-10-11 Verfahren zur Herstellung von Crystallin pyrazol[1,5-a]pyrimidin Verbindung
PCT/EP2007/060796 WO2008043799A1 (en) 2006-10-11 2007-10-10 Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound

Publications (1)

Publication Number Publication Date
ATE503758T1 true ATE503758T1 (de) 2011-04-15

Family

ID=37808282

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07821163T ATE503758T1 (de) 2006-10-11 2007-10-10 Verfahren zur herstellung einer kristallinen pyrazoloä1,5-aüpyrimidinverbindung

Country Status (23)

Country Link
US (1) US8008486B2 (de)
EP (2) EP1956021A1 (de)
JP (1) JP5270555B2 (de)
KR (1) KR101409573B1 (de)
CN (1) CN101573362B (de)
AR (1) AR065831A1 (de)
AT (1) ATE503758T1 (de)
AU (1) AU2007306318B2 (de)
BR (1) BRPI0717836A2 (de)
CA (1) CA2664900C (de)
CL (1) CL2007002929A1 (de)
DE (1) DE602007013596D1 (de)
DK (1) DK2081934T3 (de)
ES (1) ES2362631T3 (de)
MX (1) MX2009003567A (de)
NO (1) NO342009B1 (de)
PL (1) PL2081934T3 (de)
PT (1) PT2081934E (de)
RU (1) RU2404984C1 (de)
SI (1) SI2081934T1 (de)
TW (1) TWI425000B (de)
UY (1) UY30619A1 (de)
WO (1) WO2008043799A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1884516A1 (de) * 2006-08-04 2008-02-06 Ferrer Internacional, S.A. Pyrazolo[1,5-a]pyrimidine, diese enthaltende pharmazeutische Zubereitungen und ihre Verwendung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
DE60011638T2 (de) * 1999-09-02 2004-10-21 Neurocrine Biosciences Inc POLYMORPHE DES N-METHYL-N-(3-(2-THIENYLCARBONYL)-PYRAZOL[1,5-a]PYRIMIDIN-7-YL PHENYL)ACETAMID UND ZUSAMMENSTELLUNGEN UND DIESBEZÜGLICHE METHODEN
SG125971A1 (en) * 2000-08-03 2006-10-30 Wyeth Corp Variable water hydrates of zaleplon and method forthe preparation thereof
ATE343581T1 (de) * 2002-08-26 2006-11-15 Neurocrine Biosciences Inc Polymorph von n-methyl-n-(3- 3- 2-[thienylcarbonylö-pyrazol-[1,5-alphaö-pyrimidin- - yl phenyl)acetamid und zusammensetzungen sowie verfahren hierzu
ES2222813B1 (es) 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
US20060064488A1 (en) * 2004-09-17 2006-03-23 Ebert Robert F Electronic software distribution method and system using a digital rights management method based on hardware identification
EP1736475A1 (de) * 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenierte Pyrazolo[1,5-a]pyrimidine, Verfahrene, Verwendung und Zwischenprodukte

Also Published As

Publication number Publication date
DE602007013596D1 (de) 2011-05-12
US8008486B2 (en) 2011-08-30
CN101573362B (zh) 2012-06-27
TWI425000B (zh) 2014-02-01
MX2009003567A (es) 2009-04-14
CN101573362A (zh) 2009-11-04
AU2007306318A1 (en) 2008-04-17
SI2081934T1 (sl) 2011-07-29
JP5270555B2 (ja) 2013-08-21
BRPI0717836A2 (pt) 2014-05-20
EP2081934A1 (de) 2009-07-29
US20100048896A1 (en) 2010-02-25
PT2081934E (pt) 2011-06-29
HK1130250A1 (en) 2009-12-24
PL2081934T3 (pl) 2011-08-31
CA2664900C (en) 2015-07-07
CL2007002929A1 (es) 2008-05-16
EP1956021A1 (de) 2008-08-13
AU2007306318B2 (en) 2012-07-05
KR101409573B1 (ko) 2014-06-19
EP2081934B1 (de) 2011-03-30
NO20091624L (no) 2009-05-07
KR20090077806A (ko) 2009-07-15
ES2362631T3 (es) 2011-07-08
TW200825085A (en) 2008-06-16
DK2081934T3 (da) 2011-07-11
NO342009B1 (no) 2018-03-12
RU2404984C1 (ru) 2010-11-27
JP2010505913A (ja) 2010-02-25
WO2008043799A1 (en) 2008-04-17
HK1134924A1 (en) 2010-05-20
AR065831A1 (es) 2009-07-08
UY30619A1 (es) 2008-03-31
CA2664900A1 (en) 2008-04-17

Similar Documents

Publication Publication Date Title
DE602007012785D1 (de) Verfahren zur Herstellung einer Photomaske
DE602007010373D1 (de) Verfahren zur Herstellung einer Wabenstruktur
DE602006010891D1 (de) Verfahren zur herstellung einer laparoskopischen handzugriffsvorrichtung
EP2261192A4 (de) Verfahren zur herstellung einer wabenstruktur
DE602005027235D1 (de) Verfahren zur herstellung einer fotomaske
DE602005024742D1 (de) Verfahren zur Herstellung einer unpolaren einkristtrid-Halbleiter
ATE526429T1 (de) Verfahren zur herstellung einer beschichtung
EP3421006C0 (de) Verfahren zur herstellung einer zahnprothese
EP2050940A4 (de) Verfahren zur herstellung eines mehrstufigen abgasturbolader
EP1996502A4 (de) Verfahren zur herstellung einer verpackung
DE602005005101D1 (de) Verfahren zur Herstellung einer Borhydridverbindung
DE602006001883D1 (de) Verfahren zur Herstellung einer Honigwabenstruktur
AT503190A3 (de) Verfahren zur herstellung einer halbleitervorrichtung
ATE376072T1 (de) Verfahren zur herstellung einer molybdän- legierung
DE502007005615D1 (de) Verfahren zur herstellung eines piezoaktors
ATE544755T1 (de) Verfahren zur herstellung einer 5-alkoxy-4- hydroxymethylpyrazolverbindung
EP2239790A4 (de) Verfahren zur herstellung einer lichtemittierenden vorrichtung
DE602005007398D1 (de) Verfahren zur Herstellung einer Mikrolinse
DE602007009332D1 (de) Verfahren zur Herstellung einer Brennkammer
DE502007003740D1 (de) Verfahren zur herstellung einer rutschhemmenden beschichtung
DE502005005281D1 (de) Verfahren zur herstellung einer nockenwelle
ATE431318T1 (de) Verfahren zur herstellung einer aluminiumart
EP2351714A4 (de) Verfahren zur herstellung einer lichtleitfaservorform
DE502005006608D1 (de) Verfahren zur herstellung einer steckverbindung
DE602006006758D1 (de) Verfahren zur Herstellung einer Zahnstange

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2081934

Country of ref document: EP